相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mechanisms and disease consequences of nonalcoholic fatty liver disease
Rohit Loomba et al.
CELL (2021)
Loss of CD36 impairs hepatic insulin signaling by enhancing the interaction of PTP1B with IR
Ping Yang et al.
FASEB JOURNAL (2020)
The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis
Daqian Xu et al.
NATURE (2020)
Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans
Jinyun Bai et al.
EBIOMEDICINE (2020)
Progress and challenges in the prevention and control of nonalcoholic fatty liver disease
Jingjing Cai et al.
MEDICINAL RESEARCH REVIEWS (2019)
Cideb controls sterol-regulated ER export of SREBP/SCAP by promoting cargo loading at ER exit sites
Lu Su et al.
EMBO JOURNAL (2019)
Post-translational regulation of lipogenesis via AMPK-dependent phosphorylation of insulin-induced gene
Yamei Han et al.
NATURE COMMUNICATIONS (2019)
CD36 plays a negative role in the regulation of lipophagy in hepatocytes through an AMPK-dependent pathway[S]
Yun Li et al.
JOURNAL OF LIPID RESEARCH (2019)
CD36 tango in cancer: signaling pathways and functions
Jingchun Wang et al.
THERANOSTICS (2019)
CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis
Lei Zhao et al.
JOURNAL OF HEPATOLOGY (2018)
Mechanisms of NAFLD development and therapeutic strategies
Scott L. Friedman et al.
NATURE MEDICINE (2018)
Retrospective on Cholesterol Homeostasis: The Central Role of Scap
Michael S. Brown et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 87 (2018)
Endothelial cell CD36 optimizes tissue fatty acid uptake
Ni-Huiping Son et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Circulating sCD36 levels in patients with non-alcoholic fatty liver disease and controls
S. Heeboll et al.
INTERNATIONAL JOURNAL OF OBESITY (2017)
Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling
Samir Softic et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology
Hitoshi Shimano et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
CD36 in chronic kidney disease: novel insights and therapeutic opportunities
Xiaochun Yang et al.
NATURE REVIEWS NEPHROLOGY (2017)
Cluster of Differentiation 36 Deficiency Aggravates Macrophage Infiltration and Hepatic Inflammation by Upregulating Monocyte Chemotactic Protein-1 Expression of Hepatocytes Through Histone Deacetylase 2-Dependent Pathway
Shan Zhong et al.
ANTIOXIDANTS & REDOX SIGNALING (2017)
The SCAP/SREBP Pathway: A Mediator of Hepatic Steatosis
Young-Ah Moon
ENDOCRINOLOGY AND METABOLISM (2017)
Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease
Samir Softic et al.
DIGESTIVE DISEASES AND SCIENCES (2016)
Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice
Camella G. Wilson et al.
ENDOCRINOLOGY (2016)
Glucose-Mediated N-glycosylation of SCAP Is Essential for SREBP-1 Activation and Tumor Growth
Chunming Cheng et al.
CANCER CELL (2015)
Regulation of AMPK Activaticin by CD36 Links Fatty Acid Uptake to β-Oxidation
Dmitri Samovski et al.
DIABETES (2015)
Free Fatty Acid Uptake in Humans With CD36 Deficiency
Kazanna C. Hames et al.
DIABETES (2014)
Increased De Novo Lipogenesis Is a Distinct Characteristic of Individuals With Nonalcoholic Fatty Liver Disease
Jennifer E. Lambert et al.
GASTROENTEROLOGY (2014)
A novel processing system of sterol regulatory element-binding protein-1c regulated by polyunsaturated fatty acid
Masanori Nakakuki et al.
JOURNAL OF BIOCHEMISTRY (2014)
CD36-deficient mice are resistant to alcohol- and high-carbohydrate-induced hepatic steatosis
Robin D. Clugston et al.
JOURNAL OF LIPID RESEARCH (2014)
CD36 deletion reduces VLDL secretion, modulates liver prostaglandins, and exacerbates hepatic steatosis in ob/ob mice
Fatiha Nassir et al.
JOURNAL OF LIPID RESEARCH (2013)
Inhibition of SREBP by a Small Molecule, Betulin, Improves Hyperlipidemia and Insulin Resistance and Reduces Atherosclerotic Plaques
Jing-Jie Tang et al.
CELL METABOLISM (2011)
Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C
Maria Eugenia Miquilena-Colina et al.
GUT (2011)
No association between polymorphisms in the INSIG1 gene and the risk of type 2 diabetes and related traits
Magdalena Szopa et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2010)
Membrane Fatty Acid Transporters as Regulators of Lipid Metabolism: Implications for Metabolic Disease
Jan F. C. Glatz et al.
PHYSIOLOGICAL REVIEWS (2010)
Insulin-induced gene A new regulator in lipid metabolism
Dong Xiao-Ying et al.
PEPTIDES (2010)
Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?
S. Le Hellard et al.
MOLECULAR PSYCHIATRY (2009)
Cellular fatty acid uptake: a pathway under construction
Xiong Su et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2009)
Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity
Debby P. Y. Koonen et al.
DIABETES (2007)
Physiological and pathological roles of a multi-ligand receptor CD36 in atherogenesis; insights from CD36-deficient patients
Shizuya Yamashita et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2007)
Protein sensors for membrane sterols
JL Goldstein et al.
CELL (2006)
Insig required for sterol-mediated inhibition of Scap/SREBP binding to COPII proteins in vitro
LP Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Hyperlipidemic effects of dietary saturated fats mediated through PGC-1β cactivation of SREBP
JD Lin et al.
CELL (2005)
Cholesterol and 25-hydroxycholesterol inhibit activation of SREBPs by different mechanisms, both involving SCAP and insigs
CM Adams et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Pathophysiology of human genetic CD36 deficiency
K Hirano et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2003)
Insulin sensitivity and lipid metabolism in human CD36 deficiency
M Furuhashi et al.
DIABETES CARE (2003)
Dietary polyunsaturated fats regulate rat liver sterol regulatory element binding proteins-1 and-2 in three distinct stages and by different mechanisms
J Xu et al.
JOURNAL OF NUTRITION (2002)
Isoimmunization against CD36 (glycoprotein IV): description of four cases of neonatal isoimmune thrombocytopenia and brief review of the literature
BR Curtis et al.
TRANSFUSION (2002)
Unsaturated fatty acids down-regulate SREBP isoforms 1a and 1c by two mechanisms in HEK-293 cells
VC Hannah et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Promoter analysis of the mouse sterol regulatory element-binding protein-1c gene
M Amemiya-Kudo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
